Searched for
MIRABEGRON PATENT DISPUTE
Zydus settles US Mirabegron patent dispute with Astellas for $120 millionZydus Lifesciences and its US subsidiary have settled patent litigation with Astellas Pharma over Astellas' Myrbetriq. Zydus will pay Astel...- Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...
- Load More